Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules

Thyroid

Volumn 20, Issue 8, 2010, Pages 885-891

  Kim, Eun Sook ^a   Lim, Dong Jun ^a   Baek, Ki Hyun ^a   Lee, Jong Min ^a   Kim, Mee Kyoung ^a   Kwon, Hyuk Sang ^a   Song, Ki Ho ^a   Kang, Moo Ii ^a   Cha, Bong Yun ^a   Lee, Kwang Woo ^a   Son, Ho Young ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY;

ADULT; ARTICLE; ASPIRATION CYTOLOGY; AUTOIMMUNE THYROIDITIS; BENIGN TUMOR; CANCER DIAGNOSIS; CANCER RISK; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; THYROID CANCER; THYROID NODULE;

ADULT; AGED; ANTIBODIES; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CYTOLOGICAL TECHNIQUES; FEMALE; HUMANS; IODIDE PEROXIDASE; MALE; MIDDLE AGED; RISK FACTORS; THYROGLOBULIN; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE;

EID: 77955300528     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0384     Document Type: Article

References (51)

1. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA 1977 The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 7:481-493.
2. Vander JB, Gaston EA, Dawber TR 1968 The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 69:537-540.
3. Hegedüs L 2001 Thyroid ultrasound. Endocrinol Metab Clin North Am 30:339-360, viii-ix.
4. Knudsen N, Laurberg P, Perrild H, Bülow I, Ovesen L, Jørgensen T 2002 Risk factors for goiter and thyroid nodules. Thyroid 12:879-888.
5. Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, Regalbuto C, Vigneri R 1992 Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 93:363-369.
6. Wang C, Crapo LM 1997 The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 26:189-218.
7. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167.
8. Yassa L, Cibas ES, Benson CB, Frates MC, Doubilet PM, Gawande A, Moore FD, Kim BW, Nos V, Marqusee E, Larsen PR, Alexander EK 2007 Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer 111:508-516.
9. Alexander EK 2008 Approach to the patient with a cytologically indeterminate thyroid nodule. J Clin Endocrinol Metab 93:4175-4182.
10. Dailey ME, Lindsay S, Skahen R 1955 Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg 70:291-297.
11. Ott RA, Calandra DB, McCall A, Shah KH, Lawrence AM, Paloyan E 1985 The incidence of thyroid carcinoma in patients with Hashimotos thyroiditis and solitary cold nodules. Surgery 98:1202-1206.
12. Ott RA, McCall AR, McHenry C, Jarosz H, Armin A, Lawrence AM, Paloyan E 1987 The incidence of thyroid carcinoma in Hashimotos thyroiditis. Am Surg 53:442-445.
13. Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose NR 1995 Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer 76:2312-2318.
14. McConahey WM, Hay ID, Woolner LB, van Heerden JA, Taylor WF 1986 Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 61:978-996.
15. Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP 1999 Coexistent Hashimotos thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery 126:1070-1076.
16. Crile G 1978 Struma lymphomatosa and carcinoma of the thyroid. Surg Gynecol Obstet 147:350-352.
17. Holm LE, Blomgren H, Löwhagen T 1985 Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 312:601-604.
18. Rago T, Di Coscio G, Ugolini C, Scutari M, Basolo F, Latrofa F, Romani R, Berti P, Grasso L, Braverman LE, Pinchera A, Vitti P 2007 Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy. Clin Endocrinol 67:363-369.
19. Baker JR 1995 The immune response to papillary thyroid cancer. J Clin Endocrinol Metab 80:3419-3420.
20. Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA 2006 Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 91:4295-4301.
21. Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC, Chen H 2008 Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 93:809-814.
22. Wiersinga WM, Endert E, Tijssen JG, Prummel MF, Strieder TG 2003 Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol 59:396-401.
23. Fiore ERT, Provenzale MA, Scutari M, Ugolini C, Basolo F, Di Coscio G, Berti PGL, Elisei R, Pinchera AVP 2009 Lower levels of TSH are associated to a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocr Relat Cancer 16:1251-1260.
24. Arif S, Blanes A, Diaz-Cano SJ 2002 Hashimotos thyroiditis shares features with early papillary thyroid carcinoma. Histopathology 41:357-362.
25. Unger P, Ewart M, Wang BY, Gan L, Kohtz DS, Burstein DE 2003 Expression of p63 in papillary thyroid carcinoma and in Hashimotos thyroiditis: a pathobiologic link? Hum Pathol 34:764-769.
26. Wirtschafter A, Schmidt R, Rosen D, Kundu N, Santoro M, Fusco A, Multhaupt H, Atkins JP, Rosen MR, Keane WM, Rothstein JL 1997 Expression of the RET=PTC fusion gene as a marker for papillary carcinoma in Hashimotos thyroiditis. Laryngoscope 107:95-100.
27. Nikiforov YE, Biddinger P, Caudill CM, Nikiforova MN 2002 Prevalence of RET=PTC rearrangements in Hashimotos thyroiditis and papillary thyroid carcinomas. Int J Surg Pathol 10:15-22.
28. Crile G Jr, Hazard JB 1962 Incidence of cancer in struma lymphomatosa. Surg Gynecol Obstet 115:101-103.
29. Nordyke RA, Gilbert FI, Miyamoto LA, Fleury KA 1993 The superiority of antimicrosomal over antithyroglobulin antibodies for detecting Hashimotos thyroiditis. Arch Intern Med 153:862-865.
30. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry J, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR 2003 Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3-126.
31. Hjiyiannakis P, Mundy J, Harmer C 1999 Thyroglobulin antibodies in differentiated thyroid cancer. Clin Oncol 11:240-244.
32. Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, Fatemi S, LoPresti JS, Nicoloff JT 1998 Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 83:1121-1127.
33. Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, Grasso L, Pinchera A 2003 Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 139:346-351.
34. Chung JK, Park YJ, Kim TY, So Y, Kim SK, Park DJ, Lee DS, Lee MC, Cho BY 2002 Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation. Clin Endocrinol 57:215-221.
35. Kim WG, Yoon JH, Kim WB, Kim TY, Kim EY, Kim JM, Ryu J, Gong G, Hong SJ, Shong YK 2008 Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 93:4683-4689.
36. Sinclair D 2006 Clinical and laboratory aspects of thyroid autoantibodies. Ann Clin Biochem 43:173-183.
37. Latrofa F, Ricci D, Grasso L, Vitti P, Masserini L, Basolo F, Ugolini C, Mascia G, Lucacchini A, Pinchera A 2008 Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies. J Clin Endocrinol Metab 93:591-596.
38. Jonklaas J, Nsouli-Maktabi H, Soldin SJ 2008 Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer. Thyroid 18:943-952.
39. Haymart MR, Glinberg SL, Liu J, Sippel RS, Jaume JC, Chen H 2009 Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. Clin Endocrinol 71:434-439.
40. Carayon P, Thomas-Morvan C, Castanas E, Tubiana M 1980 Human thyroid cancer: membrane thyrotropin binding and adenylate cyclase activity. J Clin Endocrinol Metab 51:915-920.
41. Ichikawa Y, Saito E, Abe Y, Homma M, Muraki T 1976 Presence of TSH receptor in thyroid neoplasms. J Clin Endocrinol Metab 42:395-398.
42. Belfiore A, Giuffrida D, La Rosa GL, Ippolito O, Russo G, Fiumara A, Vigneri R, Filetti S 1989 High frequency of cancer in cold thyroid nodules occurring at young age. Acta Endocrinol 121:197-202.
43. Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, Orcutt J, Moore FD, Larsen PR, Marqusee E, Alexander EK 2006 Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab 91:3411-3417.
44. Werk EE, Vernon BM, Gonzalez JJ, Ungaro PC, McCoy RC 1984 Cancer in thyroid nodules. A community hospital survey. Arch Intern Med 144:474-476.
45. Sheils O 2005 Molecular classification and biomarker discovery in papillary thyroid carcinoma. Expert Rev Mol Diagn 5:927-946.
46. Finn SP, Smyth P, OLeary J, Sweeney EC, Sheils O 2003 Ret=PTC chimeric transcripts in an Irish cohort of sporadic papillary thyroid carcinoma. J Clin Endocrinol Metab 88:938-941.
47. National Cancer Centre, Korea 2003 Annual report of the Korea Central Cancer Registry. Available at www.ncc.re.kr, accessed February 2010.
48. McHenry CR, Walfish PG, Rosen IB 1993 Non-diagnostic fine needle aspiration biopsy: a dilemma in management of nodular thyroid disease. Am Surg 59:415-419.
49. Raber W, Kaserer K, Niederle B, Vierhapper H 2000 Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration: results of a prospective study of one hundred twenty patients. Thyroid 10:709-712.
50. Alexander EK, Hurwitz S, Heering JP, Benson CB, Frates MC, Doubilet PM, Cibas ES, Larsen PR, Marqusee E 2003 Natural history of benign solid and cystic thyroid nodules. Ann Intern Med 138:315-318.
51. Tae HJ, Lim DJ, Baek KH, Park WC, Lee YS, Choi JE, Lee JM, Kang MI, Cha BY, Son HY, Lee KW, Kang SK 2007 Diagnostic value of ultrasonography to distinguish between benign and malignant lesions in the management of thyroid nodules. Thyroid 17:461-466.